- Conditions
- Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
- Locations
-
- HM Monteprincipe Boadilla del Monte, Madrid, Spain
Clinical trial condition
Osteosarcoma Recurrent
Explore clinical trials studying Osteosarcoma Recurrent. Study availability and eligibility vary by location and protocol.
8 public trials
3 recruiting studies
Osteosarcoma Recurrent trial results
NCT07144254
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +8 more
- Locations
-
- Arthur M. Blank Children's Healthcare of Atlanta Atlanta, Georgia, United States
NCT06892678
- Conditions
- Ewing's Tumor Recurrent, Osteosarcoma Recurrent
- Locations
-
- Montefiore Medical Center The Bronx, New York, United States
NCT04651569
- Conditions
- Osteosarcoma Recurrent
- Locations
-
- Istituto Ortopedico Rizzoli Bologna, Italy
- Azienda Ospedaliero Universitaria Meyer Florence, Italy
- IRCCS Istituto Nazionale dei Tumori - S.C. Pediatria Milan, Italy
- Regina Elena National Cancer Institute IRCCS Roma, Italy
NCT04651179
- Conditions
- Osteosarcoma Metastatic, Osteosarcoma Recurrent
- Locations
-
- Istituto Nazionale Tumori Milan, Milano, Italy
- Fondazione del Piemonte per l' Oncologia IRCCS Candiolo Candiolo, Turin, Italy
- Istituto Ortopedico Rizzoli Bologna, Italy
- AOUC Azienda Ospedaliero-Universitaria Careggi Florence, Italy
Active, Not Recruiting
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
NCT03628209
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Children's Hospital of Los Angeles, USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Children's Hospital of Colorado Aurora, Colorado, United States
- Connecticut Children's Medical Center Hartford, Connecticut, United States
Active, Not Recruiting
Olaparib With Ceralasertib in Recurrent Osteosarcoma
NCT04417062
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +5 more
- Locations
-
- UCSF Benioff Children's Hospital; UCSF Pediatrics Hematology Oncology San Francisco, California, United States
- Dana Farber Cancer Institite Boston, Massachusetts, United States
- Memorial Sloan Kettering New York, United States
- MD Anderson Houston, Texas, United States
Active, Not Recruiting
SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
NCT04803877
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +7 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- University of Miami Miami, Florida, United States
- Johns Hopkins Baltimore, Maryland, United States
- University of Michigan Ann Arbor, Michigan, United States